Annotation Detail

Information
Associated Genes
BRCA2
Associated Variants
BRCA2 MUTATION
BRCA2 MUTATION
Associated Disease
BREAST CANCER 3
Source Database
DisGeNET
Description
BRCA2 carriers and BRCAX patients with IDC-P had significantly worse overall and PCa-specific survival compared with BRCA2 carriers and BRCAX patients without IDC-P (hazard ratio [HR]: 16.9, p=0.0064 and HR: 3.57, p=0.0086, respectively).
Pubmed
25154392
Section of the abstract supporting the evidence
RESULTS AND LIMITATIONS
Number of the section of the abstract supporting the evidence
5
Number of the sentence supporting the evidence
10
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.00244297684872273
Drugs